Celestica Inc. (CLS) vs Eli Lilly and Company (LLY)
A side-by-side comparison of Celestica Inc. and Eli Lilly and Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 29, 2026. Differences are shown without an overall score or investment verdict.
Different business models: CLS is classified in Technology; LLY is classified in Healthcare. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
CLS
Celestica Inc.
$328.43TechnologyDelayed quote: Jul 29, 2026, 4:00 PM EDT
LLY
Eli Lilly and Company
$1,210.02HealthcareAt close: Jul 29, 2026, 4:00 PM ET
Total return — CLS vs LLY
growth of $100 · dividends reinvested · last 28yCLS +3635.5%LLY +3515.4%CLS compounded faster
CLS LLY
CLS vs LLY: by the numbers
- •LLY is the larger company ($1.14T vs $37.76B market cap).
- •CLS trades at the lower trailing earnings multiple (36.37 vs 42.98 P/E), one valuation lens rather than an overall verdict.
- •LLY converts more revenue to profit (34.98% vs 7.16% net margin).
- •LLY grew revenue faster over the past five years (23.17% vs 22.80% CAGR).
- •LLY pays a dividend (0.53% yield), while CLS has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CLS | LLY |
|---|---|---|
| P/E ratio | 36.37 | 42.98 |
| Forward P/E | 34.58 | 34.45 |
| P/S ratio | 2.61 | 15.00 |
| P/B ratio | 16.41 | 34.75 |
| PEG ratio | 0.39 | 0.49 |
| EV / EBITDA | 29.23 | 32.30 |
| FCF yield | 1.28% | 1.25% |
Profitability
| Metric | CLS | LLY |
|---|---|---|
| Gross margin | 11.59% | 83.51% |
| Operating margin | 8.13% | 45.87% |
| Net margin | 7.16% | 34.98% |
| ROE | 45.07% | 81.01% |
| ROIC | 27.74% | 30.20% |
Dividends
| Metric | CLS | LLY |
|---|---|---|
| Dividend yield | N/A | 0.53% |
| Payout ratio | N/A | 28.09% |
Growth (annualized)
| Metric | CLS | LLY |
|---|---|---|
| Revenue CAGR (5Y) | 22.80% | 23.17% |
| EPS CAGR (5Y) | 73.33% | 28.88% |
| FCF CAGR (5Y) | 29.00% | 19.54% |
| Total return CAGR (5Y) | 108.18% | 38.90% |
Frequently asked
- Which has the lower trailing P/E, CLS or LLY?
- CLS has the lower trailing P/E: CLS trades at 36.37 and LLY at 42.98. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, CLS or LLY?
- Over the past five years, LLY grew revenue faster — CLS at a 22.80% CAGR versus LLY at 23.17%.
- Does CLS or LLY pay a bigger dividend?
- LLY pays a dividend (0.53% yield), while CLS has no payments in the available dividend history.
- Is CLS or LLY more profitable?
- LLY runs the higher net margin — CLS at 7.16% versus LLY at 34.98%.
- How have CLS and LLY total returns compared?
- Over the past 10 years, CLS delivered 41.09% and LLY delivered 32.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Celestica P/E ratioEli Lilly and P/E ratioCelestica dividend yieldEli Lilly and dividend yieldCelestica ROEEli Lilly and ROECelestica operating marginEli Lilly and operating marginCelestica revenue growthEli Lilly and revenue growthCelestica free cash flowEli Lilly and free cash flow
Celestica & Eli Lilly and appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 29, 2026.